References
[1] Patel RM, Underwood MA. Probiotics and necrotizing enterocolitis[J]. Semin Pediatr Surg, 2018, 27(1):39-46.
[2] Eaton S, Rees CM, Hall NJ. Current research on the epidemiology, pathogenesis, and management of necrotizing enterocolitis[J]. Neonatology, 2017, 111(4):423-430.
[3] Treszl A, Heninger E, Kalman A, et al. Lower prevalence of IL-4 receptor alpha-chain gene G variant in very-low-birth-weight infants with necrotizing enterocolitis[J]. J Pediatr Surg, 2003, 38(9):1374-1378.
[4] Cuna A, Sampath V. Genetic alterations in necrotizing enterocolitis[J]. Semin Perinatol, 2017, 41(1):61-69.
[5] 袁媛, 周伟, 袁伟明, 等. MD-2和GM2A基因多态性与新生儿坏死性小肠结肠炎的关系[J]. 中国新生儿科杂志, 2015, 30(1):3-8.
[6] Babaie F, Hasankhani M, Mohammadi H, et al. The role of gut microbiota and IL-23/IL-17 pathway in ankylosing spondylitis immunopathogenesis:new insights and updates[J]. Immunol Lett, 2018, 196:52-62.
[7] Kim SW, Kim ES, Moon CM, et al. Genetic polymorphisms of IL-23R and IL-17A and novel insights into their associations with inflammatory bowel disease[J]. Gut, 2011, 60(11):1527-1536.
[8] Bell MJ, Ternberg JL, Feigin RD, et al. Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging[J]. Ann Surg, 1978, 187(1):1-7.
[9] Ma F, Li S, Gao X, et al. Interleukin-6-mediated CCR9+ interleukin-17-producing regulatory T cells polarization increases the severity of necrotizing enterocolitis[J]. EBioMedicine, 2019, 44:71-85.
[10] Lawrence SM, Ruoss JL, Wynn JL. IL-17 in neonatal health and disease[J]. Am J Reprod Immunol, 2018, 79(5):e12800.
[11] 金汉珍. 新生儿坏死性小肠结肠炎[M]//胡亚美, 江载芳. 诸福棠实用儿科学(上册). 第7版. 北京:人民卫生出版社, 2005:475.
[12] McGovern D, Powrie F. The IL23 axis plays a key role in the pathogenesis of IBD[J]. Gut, 2007, 56(10):1333-1336.
[13] Walsh MC, Kliegman RM. Necrotizing enterocolitis:treatment based on staging criteria[J]. Pediatr Clin North Am, 1986, 33(1):179-201.
[14] Luo Y, Luo J, Peng H. Associations between genetic polymorphisms in the VEGFA, ACE, and SOD2 genes and susceptibility to diabetic nephropathy in the Han Chinese[J]. Genet Test Mol Biomarkers, 2019, 23(9):644-651.
[15] 刘杰, 周晓慧, 史乾, 等. IL-17家族细胞因子的功能及其在相关疾病中的作用[J]. 现代免疫学, 2014, 34(3):262-265.
[16] Hammad A, Mosaad YM, Hammad EM, et al. Interleukin-17A rs2275913, Interleukin-17F rs763780 and rs2397084 gene polymorphisms as possible risk factors in Juvenile lupus and lupus related nephritis[J]. Autoimmunity, 2016, 49(1):31-40.
[17] Jiang L, Zhou X, Xiong Y, et al. Association between interleukin-17A/F single nucleotide polymorphisms and susceptibility to osteoarthritis in a Chinese population[J]. Medicine (Baltimore), 2019, 98(12):e14944.
[18] Eskandari-Nasab E, Moghadampour M, Tahmasebi A. Meta-analysis of risk association between interleukin-17A and F gene polymorphisms and inflammatory diseases[J]. J Interferon Cytokine Res, 2017, 37(4):165-174.
[19] Egan CE, Sodhi CP, Good M, et al. Toll-like receptor 4-mediated lymphocyte influx induces neonatal necrotizing enterocolitis[J]. J Clin Invest, 2016, 126(2):495-508.
[20] Gao X, Ma F, Hao H, et al. Association of VEGFA polymorphisms with necrotizing enterocolitis in Chinese Han population[J]. Pediatr Neonatol, 2019, 60(2):129-134.